Severe community-acquired pneumonia due to Staphylococcus aureus, 2003-04 influenza season
- Jeffrey C. Hageman(corresponding author),
- Timothy M. Uyeki,
- John S. Francis,
- Daniel B. Jernigan,
- J. Gary Wheeler,
- Carolyn B. Bridges
- Centers for Disease Control and Prevention,
- Johns Hopkins University,
- University of Arkansas for Medical Sciences,
- Saint Louis University,
- Michigan Department of Community Health,
- National Institutes of Health, Bethesda
Open access
Sustainable Development Goals
- SDG 3 Good Health and Well
Abstract
During the 2003-04 influenza season, 17 cases of Staphylococcus aureus community-acquired pneumonia (CAP) were reported from 9 states; 15 (88%) were associated with methicillin-resistant S. aureus (MRSA). The median age of patients was 21 years; 5 (29%) had underlying diseases, and 4 (24%) had risk factors for MRSA. Twelve (71%) had laboratory evidence of influenza virus infection. All but 1 patient, who died on arrival, were hospitalized. Death occurred in 5 (4 with MRSA). S. aureus isolates were available from 13 (76%) patients (11 MRSA). Toxin genes were detected in all isolates; 11 (85%) had only genes for Panton-Valentine leukocidin. All isolates had community-associated pulsed-field gel electrophoresis patterns; all MRSA isolates had the staphylococcal cassette chromosome mec type IVa. In communities with a high prevalence of MRSA, empiric therapy of severe CAP during periods of high influenza activity should include consideration for MRSA.
Publication Information
Output type
Original language
English (US)Pages from-to (Number of pages)
Pages 894-899 (6 pages)Journal (Volume, Issue Number)
Emerging Infectious Diseases (Volume 12, Issue 6)Publication milestones
- Published - 2006
Publication status
ISSN
1080-6040Publication IDs
- Scopus: 33744947566
- PubMed: 16707043
